Across the four key areas of pharmaceutical formulation, controlled-release systems, tissue engineering, and biocompatibility testing, PLLA microspheres serve as essential R&D consumables:
Pharmaceutical formulation development: Loading model drugs to validate sustained- or controlled-release mechanisms;
Controlled-release system research: Acting as "dumbbell-shaped" carriers to investigate release kinetics and burst-release behavior;
Tissue engineering scaffolds: Compounded with collagen or hyaluronic acid to evaluate cell adhesion, proliferation, and differentiation;
Biomaterial biocompatibility testing: Enabling comprehensive assessment of acute, sub-acute, and chronic toxicity, as well as hemocompatibility and genotoxicity.
In short: They turn "what if" into "what is possible," rather than being products intended for direct patient use.

